nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2D6—breast cancer	0.136	0.538	CbGaD
Methimazole—CYP3A4—breast cancer	0.117	0.462	CbGaD
Methimazole—CYP2A6—Letrozole—breast cancer	0.071	0.134	CbGbCtD
Methimazole—CYP2B6—Thiotepa—breast cancer	0.0312	0.0587	CbGbCtD
Methimazole—CYP1A2—Anastrozole—breast cancer	0.0242	0.0454	CbGbCtD
Methimazole—CYP1A2—Toremifene—breast cancer	0.0221	0.0416	CbGbCtD
Methimazole—CYP2C9—Anastrozole—breast cancer	0.0218	0.0409	CbGbCtD
Methimazole—CYP2A6—Tamoxifen—breast cancer	0.0211	0.0398	CbGbCtD
Methimazole—CYP2B6—Raloxifene—breast cancer	0.0208	0.0392	CbGbCtD
Methimazole—CYP2C19—Lapatinib—breast cancer	0.0175	0.0329	CbGbCtD
Methimazole—CYP3A4—Exemestane—breast cancer	0.0167	0.0314	CbGbCtD
Methimazole—CYP2C9—Idarubicin—breast cancer	0.0165	0.031	CbGbCtD
Methimazole—CYP2A6—Fluorouracil—breast cancer	0.0156	0.0293	CbGbCtD
Methimazole—CYP2D6—Idarubicin—breast cancer	0.0151	0.0284	CbGbCtD
Methimazole—CYP3A4—Letrozole—breast cancer	0.0142	0.0267	CbGbCtD
Methimazole—CYP2E1—Tamoxifen—breast cancer	0.014	0.0262	CbGbCtD
Methimazole—CYP2B6—Tamoxifen—breast cancer	0.0138	0.0259	CbGbCtD
Methimazole—CYP2E1—Mitoxantrone—breast cancer	0.0136	0.0256	CbGbCtD
Methimazole—CYP3A4—Anastrozole—breast cancer	0.0127	0.0238	CbGbCtD
Methimazole—CYP3A4—Toremifene—breast cancer	0.0116	0.0218	CbGbCtD
Methimazole—CYP3A4—Fulvestrant—breast cancer	0.0108	0.0202	CbGbCtD
Methimazole—CYP2B6—Irinotecan—breast cancer	0.0106	0.0199	CbGbCtD
Methimazole—CYP3A4—Thiotepa—breast cancer	0.00959	0.018	CbGbCtD
Methimazole—CYP2C9—Capecitabine—breast cancer	0.00904	0.017	CbGbCtD
Methimazole—CYP3A4—Ixabepilone—breast cancer	0.00877	0.0165	CbGbCtD
Methimazole—CYP2C19—Tamoxifen—breast cancer	0.00875	0.0165	CbGbCtD
Methimazole—CYP3A4—Lapatinib—breast cancer	0.00844	0.0159	CbGbCtD
Methimazole—CYP1A2—Tamoxifen—breast cancer	0.00807	0.0152	CbGbCtD
Methimazole—CYP2D6—Vinorelbine—breast cancer	0.00737	0.0139	CbGbCtD
Methimazole—CYP2C9—Tamoxifen—breast cancer	0.00727	0.0137	CbGbCtD
Methimazole—CYP2D6—Tamoxifen—breast cancer	0.00665	0.0125	CbGbCtD
Methimazole—CYP3A4—Raloxifene—breast cancer	0.0064	0.012	CbGbCtD
Methimazole—CYP1A2—Fluorouracil—breast cancer	0.00595	0.0112	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—breast cancer	0.00577	0.0109	CbGbCtD
Methimazole—CYP2C9—Paclitaxel—breast cancer	0.00566	0.0106	CbGbCtD
Methimazole—CYP2C9—Fluorouracil—breast cancer	0.00536	0.0101	CbGbCtD
Methimazole—CYP3A4—Vinorelbine—breast cancer	0.00468	0.00881	CbGbCtD
Methimazole—CYP2D6—Vinblastine—breast cancer	0.00454	0.00854	CbGbCtD
Methimazole—CYP3A4—Tamoxifen—breast cancer	0.00423	0.00795	CbGbCtD
Methimazole—CYP3A4—Mitoxantrone—breast cancer	0.00412	0.00776	CbGbCtD
Methimazole—CYP3A4—Paclitaxel—breast cancer	0.00329	0.00619	CbGbCtD
Methimazole—CYP3A4—Irinotecan—breast cancer	0.00325	0.00611	CbGbCtD
Methimazole—CYP3A4—Vinblastine—breast cancer	0.00289	0.00543	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—breast cancer	0.00279	0.00525	CbGbCtD
Methimazole—CYP3A4—Docetaxel—breast cancer	0.00238	0.00448	CbGbCtD
Methimazole—CYP3A4—Doxorubicin—breast cancer	0.00177	0.00334	CbGbCtD
Methimazole—Dyspepsia—Goserelin—breast cancer	0.000197	0.00166	CcSEcCtD
Methimazole—Alopecia—Fluorouracil—breast cancer	0.000197	0.00166	CcSEcCtD
Methimazole—Lymphadenopathy—Methotrexate—breast cancer	0.000196	0.00166	CcSEcCtD
Methimazole—Thrombocytopenia—Vinorelbine—breast cancer	0.000196	0.00166	CcSEcCtD
Methimazole—Nausea—Idarubicin—breast cancer	0.000193	0.00163	CcSEcCtD
Methimazole—Nausea—Raloxifene—breast cancer	0.000193	0.00163	CcSEcCtD
Methimazole—Aplastic anaemia—Doxorubicin—breast cancer	0.000187	0.00158	CcSEcCtD
Methimazole—Thrombocytopenia—Thiotepa—breast cancer	0.000187	0.00158	CcSEcCtD
Methimazole—Pruritus—Chlorambucil—breast cancer	0.000186	0.00157	CcSEcCtD
Methimazole—Urticaria—Tamoxifen—breast cancer	0.000186	0.00157	CcSEcCtD
Methimazole—Lymphadenopathy—Epirubicin—breast cancer	0.000183	0.00155	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Vinorelbine—breast cancer	0.000182	0.00154	CcSEcCtD
Methimazole—Urticaria—Melphalan—breast cancer	0.000182	0.00154	CcSEcCtD
Methimazole—Vertigo—Irinotecan—breast cancer	0.000182	0.00154	CcSEcCtD
Methimazole—Leukopenia—Mitoxantrone—breast cancer	0.000181	0.00153	CcSEcCtD
Methimazole—Leukopenia—Irinotecan—breast cancer	0.000181	0.00153	CcSEcCtD
Methimazole—Paraesthesia—Vinorelbine—breast cancer	0.00018	0.00152	CcSEcCtD
Methimazole—Urticaria—Goserelin—breast cancer	0.000177	0.0015	CcSEcCtD
Methimazole—Body temperature increased—Goserelin—breast cancer	0.000177	0.00149	CcSEcCtD
Methimazole—Leukopenia—Gemcitabine—breast cancer	0.000176	0.00149	CcSEcCtD
Methimazole—Neuropathy peripheral—Docetaxel—breast cancer	0.000175	0.00148	CcSEcCtD
Methimazole—Jaundice—Docetaxel—breast cancer	0.000174	0.00147	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Thiotepa—breast cancer	0.000174	0.00147	CcSEcCtD
Methimazole—Leukopenia—Fluorouracil—breast cancer	0.000173	0.00147	CcSEcCtD
Methimazole—Arthralgia—Mitoxantrone—breast cancer	0.000172	0.00146	CcSEcCtD
Methimazole—Myalgia—Mitoxantrone—breast cancer	0.000172	0.00146	CcSEcCtD
Methimazole—Paraesthesia—Thiotepa—breast cancer	0.000172	0.00145	CcSEcCtD
Methimazole—Somnolence—Thiotepa—breast cancer	0.00017	0.00144	CcSEcCtD
Methimazole—Lymphadenopathy—Doxorubicin—breast cancer	0.00017	0.00144	CcSEcCtD
Methimazole—Neuropathy peripheral—Capecitabine—breast cancer	0.00017	0.00144	CcSEcCtD
Methimazole—Jaundice—Capecitabine—breast cancer	0.000169	0.00143	CcSEcCtD
Methimazole—Dyspepsia—Thiotepa—breast cancer	0.000168	0.00142	CcSEcCtD
Methimazole—Myalgia—Gemcitabine—breast cancer	0.000168	0.00142	CcSEcCtD
Methimazole—Arthralgia—Gemcitabine—breast cancer	0.000168	0.00142	CcSEcCtD
Methimazole—Alopecia—Paclitaxel—breast cancer	0.000167	0.00142	CcSEcCtD
Methimazole—Vomiting—Chlorambucil—breast cancer	0.000167	0.00141	CcSEcCtD
Methimazole—Agranulocytosis—Docetaxel—breast cancer	0.000167	0.00141	CcSEcCtD
Methimazole—Pruritus—Tamoxifen—breast cancer	0.000165	0.0014	CcSEcCtD
Methimazole—Oedema—Mitoxantrone—breast cancer	0.000165	0.0014	CcSEcCtD
Methimazole—Oedema—Irinotecan—breast cancer	0.000165	0.0014	CcSEcCtD
Methimazole—Myalgia—Fluorouracil—breast cancer	0.000165	0.00139	CcSEcCtD
Methimazole—Pruritus—Melphalan—breast cancer	0.000162	0.00137	CcSEcCtD
Methimazole—Agranulocytosis—Capecitabine—breast cancer	0.000162	0.00137	CcSEcCtD
Methimazole—Thrombocytopenia—Mitoxantrone—breast cancer	0.000162	0.00137	CcSEcCtD
Methimazole—Thrombocytopenia—Irinotecan—breast cancer	0.000162	0.00137	CcSEcCtD
Methimazole—Oedema—Gemcitabine—breast cancer	0.000161	0.00136	CcSEcCtD
Methimazole—Hepatitis—Docetaxel—breast cancer	0.000161	0.00136	CcSEcCtD
Methimazole—Urticaria—Vinorelbine—breast cancer	0.000159	0.00134	CcSEcCtD
Methimazole—Body temperature increased—Vinorelbine—breast cancer	0.000158	0.00134	CcSEcCtD
Methimazole—Pruritus—Goserelin—breast cancer	0.000158	0.00134	CcSEcCtD
Methimazole—Oedema—Fluorouracil—breast cancer	0.000158	0.00134	CcSEcCtD
Methimazole—Thrombocytopenia—Gemcitabine—breast cancer	0.000157	0.00133	CcSEcCtD
Methimazole—Nausea—Chlorambucil—breast cancer	0.000156	0.00132	CcSEcCtD
Methimazole—Hepatitis—Capecitabine—breast cancer	0.000155	0.00131	CcSEcCtD
Methimazole—Thrombocytopenia—Fluorouracil—breast cancer	0.000155	0.00131	CcSEcCtD
Methimazole—Vomiting—Vinblastine—breast cancer	0.000153	0.00129	CcSEcCtD
Methimazole—Urticaria—Thiotepa—breast cancer	0.000152	0.00128	CcSEcCtD
Methimazole—Body temperature increased—Thiotepa—breast cancer	0.000151	0.00128	CcSEcCtD
Methimazole—Headache—Vinblastine—breast cancer	0.000151	0.00128	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.00015	0.00127	CcSEcCtD
Methimazole—Vomiting—Tamoxifen—breast cancer	0.000149	0.00126	CcSEcCtD
Methimazole—Paraesthesia—Mitoxantrone—breast cancer	0.000148	0.00125	CcSEcCtD
Methimazole—Paraesthesia—Irinotecan—breast cancer	0.000148	0.00125	CcSEcCtD
Methimazole—Vertigo—Paclitaxel—breast cancer	0.000148	0.00125	CcSEcCtD
Methimazole—Leukopenia—Paclitaxel—breast cancer	0.000148	0.00125	CcSEcCtD
Methimazole—Rash—Tamoxifen—breast cancer	0.000147	0.00125	CcSEcCtD
Methimazole—Dermatitis—Tamoxifen—breast cancer	0.000147	0.00125	CcSEcCtD
Methimazole—Somnolence—Mitoxantrone—breast cancer	0.000147	0.00124	CcSEcCtD
Methimazole—Somnolence—Irinotecan—breast cancer	0.000147	0.00124	CcSEcCtD
Methimazole—Headache—Tamoxifen—breast cancer	0.000146	0.00124	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000146	0.00124	CcSEcCtD
Methimazole—Vomiting—Melphalan—breast cancer	0.000146	0.00123	CcSEcCtD
Methimazole—Dyspepsia—Mitoxantrone—breast cancer	0.000145	0.00123	CcSEcCtD
Methimazole—Dyspepsia—Irinotecan—breast cancer	0.000145	0.00123	CcSEcCtD
Methimazole—Rash—Melphalan—breast cancer	0.000144	0.00122	CcSEcCtD
Methimazole—Paraesthesia—Gemcitabine—breast cancer	0.000144	0.00122	CcSEcCtD
Methimazole—Dermatitis—Melphalan—breast cancer	0.000144	0.00122	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000144	0.00122	CcSEcCtD
Methimazole—Nausea—Vinblastine—breast cancer	0.000143	0.00121	CcSEcCtD
Methimazole—Somnolence—Gemcitabine—breast cancer	0.000143	0.00121	CcSEcCtD
Methimazole—Vomiting—Goserelin—breast cancer	0.000142	0.0012	CcSEcCtD
Methimazole—Paraesthesia—Fluorouracil—breast cancer	0.000142	0.0012	CcSEcCtD
Methimazole—Alopecia—Docetaxel—breast cancer	0.000142	0.0012	CcSEcCtD
Methimazole—Pruritus—Vinorelbine—breast cancer	0.000142	0.0012	CcSEcCtD
Methimazole—Rash—Goserelin—breast cancer	0.000141	0.00119	CcSEcCtD
Methimazole—Dermatitis—Goserelin—breast cancer	0.000141	0.00119	CcSEcCtD
Methimazole—Somnolence—Fluorouracil—breast cancer	0.00014	0.00119	CcSEcCtD
Methimazole—Myalgia—Paclitaxel—breast cancer	0.00014	0.00119	CcSEcCtD
Methimazole—Arthralgia—Paclitaxel—breast cancer	0.00014	0.00119	CcSEcCtD
Methimazole—Headache—Goserelin—breast cancer	0.00014	0.00118	CcSEcCtD
Methimazole—Dyspepsia—Fluorouracil—breast cancer	0.000139	0.00118	CcSEcCtD
Methimazole—Nausea—Tamoxifen—breast cancer	0.000139	0.00117	CcSEcCtD
Methimazole—Alopecia—Capecitabine—breast cancer	0.000137	0.00116	CcSEcCtD
Methimazole—Nausea—Melphalan—breast cancer	0.000136	0.00115	CcSEcCtD
Methimazole—Pruritus—Thiotepa—breast cancer	0.000135	0.00114	CcSEcCtD
Methimazole—Oedema—Paclitaxel—breast cancer	0.000135	0.00114	CcSEcCtD
Methimazole—Nausea—Goserelin—breast cancer	0.000133	0.00112	CcSEcCtD
Methimazole—Thrombocytopenia—Paclitaxel—breast cancer	0.000132	0.00111	CcSEcCtD
Methimazole—Urticaria—Mitoxantrone—breast cancer	0.000131	0.00111	CcSEcCtD
Methimazole—Body temperature increased—Irinotecan—breast cancer	0.00013	0.0011	CcSEcCtD
Methimazole—Body temperature increased—Mitoxantrone—breast cancer	0.00013	0.0011	CcSEcCtD
Methimazole—Drowsiness—Methotrexate—breast cancer	0.000129	0.00109	CcSEcCtD
Methimazole—Vomiting—Vinorelbine—breast cancer	0.000127	0.00108	CcSEcCtD
Methimazole—Body temperature increased—Gemcitabine—breast cancer	0.000127	0.00107	CcSEcCtD
Methimazole—Rash—Vinorelbine—breast cancer	0.000126	0.00107	CcSEcCtD
Methimazole—Dermatitis—Vinorelbine—breast cancer	0.000126	0.00107	CcSEcCtD
Methimazole—Urticaria—Fluorouracil—breast cancer	0.000126	0.00106	CcSEcCtD
Methimazole—Headache—Vinorelbine—breast cancer	0.000125	0.00106	CcSEcCtD
Methimazole—Leukopenia—Docetaxel—breast cancer	0.000125	0.00106	CcSEcCtD
Methimazole—Body temperature increased—Fluorouracil—breast cancer	0.000125	0.00106	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000123	0.00104	CcSEcCtD
Methimazole—Vertigo—Capecitabine—breast cancer	0.000122	0.00103	CcSEcCtD
Methimazole—Vomiting—Thiotepa—breast cancer	0.000121	0.00103	CcSEcCtD
Methimazole—Leukopenia—Capecitabine—breast cancer	0.000121	0.00102	CcSEcCtD
Methimazole—Paraesthesia—Paclitaxel—breast cancer	0.000121	0.00102	CcSEcCtD
Methimazole—Drowsiness—Epirubicin—breast cancer	0.000121	0.00102	CcSEcCtD
Methimazole—Rash—Thiotepa—breast cancer	0.00012	0.00102	CcSEcCtD
Methimazole—Dermatitis—Thiotepa—breast cancer	0.00012	0.00102	CcSEcCtD
Methimazole—Agranulocytosis—Methotrexate—breast cancer	0.00012	0.00102	CcSEcCtD
Methimazole—Headache—Thiotepa—breast cancer	0.00012	0.00101	CcSEcCtD
Methimazole—Somnolence—Paclitaxel—breast cancer	0.00012	0.00101	CcSEcCtD
Methimazole—Myalgia—Docetaxel—breast cancer	0.000119	0.00101	CcSEcCtD
Methimazole—Arthralgia—Docetaxel—breast cancer	0.000119	0.00101	CcSEcCtD
Methimazole—Nausea—Vinorelbine—breast cancer	0.000119	0.00101	CcSEcCtD
Methimazole—Dyspepsia—Paclitaxel—breast cancer	0.000118	0.001	CcSEcCtD
Methimazole—Neuropathy peripheral—Epirubicin—breast cancer	0.000118	0.001	CcSEcCtD
Methimazole—Jaundice—Epirubicin—breast cancer	0.000118	0.000994	CcSEcCtD
Methimazole—Hepatitis—Methotrexate—breast cancer	0.000116	0.000979	CcSEcCtD
Methimazole—Myalgia—Capecitabine—breast cancer	0.000115	0.000974	CcSEcCtD
Methimazole—Arthralgia—Capecitabine—breast cancer	0.000115	0.000974	CcSEcCtD
Methimazole—Oedema—Docetaxel—breast cancer	0.000114	0.000965	CcSEcCtD
Methimazole—Pruritus—Gemcitabine—breast cancer	0.000114	0.000962	CcSEcCtD
Methimazole—Nausea—Thiotepa—breast cancer	0.000113	0.00096	CcSEcCtD
Methimazole—Agranulocytosis—Epirubicin—breast cancer	0.000113	0.000952	CcSEcCtD
Methimazole—Pruritus—Fluorouracil—breast cancer	0.000112	0.000946	CcSEcCtD
Methimazole—Thrombocytopenia—Docetaxel—breast cancer	0.000112	0.000945	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—breast cancer	0.000112	0.000944	CcSEcCtD
Methimazole—Oedema—Capecitabine—breast cancer	0.00011	0.000934	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—breast cancer	0.000109	0.000925	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—breast cancer	0.000109	0.00092	CcSEcCtD
Methimazole—Hepatitis—Epirubicin—breast cancer	0.000108	0.000916	CcSEcCtD
Methimazole—Thrombocytopenia—Capecitabine—breast cancer	0.000108	0.000914	CcSEcCtD
Methimazole—Urticaria—Paclitaxel—breast cancer	0.000107	0.000904	CcSEcCtD
Methimazole—Body temperature increased—Paclitaxel—breast cancer	0.000106	0.0009	CcSEcCtD
Methimazole—Vomiting—Mitoxantrone—breast cancer	0.000105	0.000887	CcSEcCtD
Methimazole—Vomiting—Irinotecan—breast cancer	0.000105	0.000887	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—breast cancer	0.000104	0.000881	CcSEcCtD
Methimazole—Rash—Mitoxantrone—breast cancer	0.000104	0.00088	CcSEcCtD
Methimazole—Rash—Irinotecan—breast cancer	0.000104	0.00088	CcSEcCtD
Methimazole—Dermatitis—Mitoxantrone—breast cancer	0.000104	0.000879	CcSEcCtD
Methimazole—Dermatitis—Irinotecan—breast cancer	0.000104	0.000879	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000104	0.000879	CcSEcCtD
Methimazole—Headache—Mitoxantrone—breast cancer	0.000103	0.000874	CcSEcCtD
Methimazole—Headache—Irinotecan—breast cancer	0.000103	0.000874	CcSEcCtD
Methimazole—Paraesthesia—Docetaxel—breast cancer	0.000102	0.000866	CcSEcCtD
Methimazole—Alopecia—Methotrexate—breast cancer	0.000102	0.000865	CcSEcCtD
Methimazole—Vomiting—Gemcitabine—breast cancer	0.000102	0.000864	CcSEcCtD
Methimazole—Somnolence—Docetaxel—breast cancer	0.000101	0.000858	CcSEcCtD
Methimazole—Rash—Gemcitabine—breast cancer	0.000101	0.000857	CcSEcCtD
Methimazole—Dermatitis—Gemcitabine—breast cancer	0.000101	0.000856	CcSEcCtD
Methimazole—Headache—Gemcitabine—breast cancer	0.000101	0.000852	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000101	0.000851	CcSEcCtD
Methimazole—Vomiting—Fluorouracil—breast cancer	0.0001	0.00085	CcSEcCtD
Methimazole—Dyspepsia—Docetaxel—breast cancer	0.0001	0.000849	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—breast cancer	0.0001	0.000847	CcSEcCtD
Methimazole—Rash—Fluorouracil—breast cancer	9.96e-05	0.000843	CcSEcCtD
Methimazole—Dermatitis—Fluorouracil—breast cancer	9.95e-05	0.000842	CcSEcCtD
Methimazole—Paraesthesia—Capecitabine—breast cancer	9.91e-05	0.000839	CcSEcCtD
Methimazole—Headache—Fluorouracil—breast cancer	9.9e-05	0.000837	CcSEcCtD
Methimazole—Nausea—Mitoxantrone—breast cancer	9.8e-05	0.000829	CcSEcCtD
Methimazole—Nausea—Irinotecan—breast cancer	9.8e-05	0.000829	CcSEcCtD
Methimazole—Dyspepsia—Capecitabine—breast cancer	9.72e-05	0.000822	CcSEcCtD
Methimazole—Alopecia—Epirubicin—breast cancer	9.57e-05	0.000809	CcSEcCtD
Methimazole—Nausea—Gemcitabine—breast cancer	9.55e-05	0.000807	CcSEcCtD
Methimazole—Pruritus—Paclitaxel—breast cancer	9.52e-05	0.000805	CcSEcCtD
Methimazole—Nausea—Fluorouracil—breast cancer	9.38e-05	0.000794	CcSEcCtD
Methimazole—Vertigo—Methotrexate—breast cancer	9.05e-05	0.000765	CcSEcCtD
Methimazole—Body temperature increased—Docetaxel—breast cancer	9.01e-05	0.000763	CcSEcCtD
Methimazole—Leukopenia—Methotrexate—breast cancer	9.01e-05	0.000763	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—breast cancer	8.85e-05	0.000749	CcSEcCtD
Methimazole—Urticaria—Capecitabine—breast cancer	8.77e-05	0.000742	CcSEcCtD
Methimazole—Body temperature increased—Capecitabine—breast cancer	8.73e-05	0.000738	CcSEcCtD
Methimazole—Myalgia—Methotrexate—breast cancer	8.57e-05	0.000725	CcSEcCtD
Methimazole—Arthralgia—Methotrexate—breast cancer	8.57e-05	0.000725	CcSEcCtD
Methimazole—Vomiting—Paclitaxel—breast cancer	8.55e-05	0.000724	CcSEcCtD
Methimazole—Rash—Paclitaxel—breast cancer	8.48e-05	0.000718	CcSEcCtD
Methimazole—Dermatitis—Paclitaxel—breast cancer	8.48e-05	0.000717	CcSEcCtD
Methimazole—Vertigo—Epirubicin—breast cancer	8.47e-05	0.000716	CcSEcCtD
Methimazole—Leukopenia—Epirubicin—breast cancer	8.44e-05	0.000714	CcSEcCtD
Methimazole—Headache—Paclitaxel—breast cancer	8.43e-05	0.000713	CcSEcCtD
Methimazole—Pruritus—Docetaxel—breast cancer	8.07e-05	0.000683	CcSEcCtD
Methimazole—Thrombocytopenia—Methotrexate—breast cancer	8.05e-05	0.000681	CcSEcCtD
Methimazole—Arthralgia—Epirubicin—breast cancer	8.02e-05	0.000679	CcSEcCtD
Methimazole—Myalgia—Epirubicin—breast cancer	8.02e-05	0.000679	CcSEcCtD
Methimazole—Nausea—Paclitaxel—breast cancer	7.99e-05	0.000676	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—breast cancer	7.83e-05	0.000663	CcSEcCtD
Methimazole—Pruritus—Capecitabine—breast cancer	7.81e-05	0.000661	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—breast cancer	7.81e-05	0.00066	CcSEcCtD
Methimazole—Oedema—Epirubicin—breast cancer	7.69e-05	0.000651	CcSEcCtD
Methimazole—Thrombocytopenia—Epirubicin—breast cancer	7.53e-05	0.000637	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Methotrexate—breast cancer	7.49e-05	0.000633	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—breast cancer	7.42e-05	0.000628	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—breast cancer	7.42e-05	0.000628	CcSEcCtD
Methimazole—Paraesthesia—Methotrexate—breast cancer	7.38e-05	0.000624	CcSEcCtD
Methimazole—Somnolence—Methotrexate—breast cancer	7.31e-05	0.000618	CcSEcCtD
Methimazole—Vomiting—Docetaxel—breast cancer	7.25e-05	0.000613	CcSEcCtD
Methimazole—Dyspepsia—Methotrexate—breast cancer	7.23e-05	0.000612	CcSEcCtD
Methimazole—Rash—Docetaxel—breast cancer	7.19e-05	0.000608	CcSEcCtD
Methimazole—Dermatitis—Docetaxel—breast cancer	7.18e-05	0.000608	CcSEcCtD
Methimazole—Headache—Docetaxel—breast cancer	7.14e-05	0.000604	CcSEcCtD
Methimazole—Oedema—Doxorubicin—breast cancer	7.12e-05	0.000602	CcSEcCtD
Methimazole—Vomiting—Capecitabine—breast cancer	7.02e-05	0.000594	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Epirubicin—breast cancer	7.01e-05	0.000593	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—breast cancer	6.97e-05	0.000589	CcSEcCtD
Methimazole—Rash—Capecitabine—breast cancer	6.96e-05	0.000589	CcSEcCtD
Methimazole—Dermatitis—Capecitabine—breast cancer	6.96e-05	0.000588	CcSEcCtD
Methimazole—Headache—Capecitabine—breast cancer	6.92e-05	0.000585	CcSEcCtD
Methimazole—Paraesthesia—Epirubicin—breast cancer	6.91e-05	0.000584	CcSEcCtD
Methimazole—Somnolence—Epirubicin—breast cancer	6.84e-05	0.000578	CcSEcCtD
Methimazole—Nausea—Docetaxel—breast cancer	6.77e-05	0.000573	CcSEcCtD
Methimazole—Dyspepsia—Epirubicin—breast cancer	6.77e-05	0.000573	CcSEcCtD
Methimazole—Nausea—Capecitabine—breast cancer	6.56e-05	0.000555	CcSEcCtD
Methimazole—Urticaria—Methotrexate—breast cancer	6.53e-05	0.000552	CcSEcCtD
Methimazole—Body temperature increased—Methotrexate—breast cancer	6.5e-05	0.00055	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.48e-05	0.000549	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—breast cancer	6.39e-05	0.000541	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—breast cancer	6.33e-05	0.000535	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—breast cancer	6.26e-05	0.00053	CcSEcCtD
Methimazole—Urticaria—Epirubicin—breast cancer	6.11e-05	0.000517	CcSEcCtD
Methimazole—Body temperature increased—Epirubicin—breast cancer	6.08e-05	0.000514	CcSEcCtD
Methimazole—Pruritus—Methotrexate—breast cancer	5.82e-05	0.000492	CcSEcCtD
Methimazole—Urticaria—Doxorubicin—breast cancer	5.65e-05	0.000478	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—breast cancer	5.63e-05	0.000476	CcSEcCtD
Methimazole—Pruritus—Epirubicin—breast cancer	5.44e-05	0.00046	CcSEcCtD
Methimazole—Vomiting—Methotrexate—breast cancer	5.23e-05	0.000442	CcSEcCtD
Methimazole—Rash—Methotrexate—breast cancer	5.18e-05	0.000438	CcSEcCtD
Methimazole—Dermatitis—Methotrexate—breast cancer	5.18e-05	0.000438	CcSEcCtD
Methimazole—Headache—Methotrexate—breast cancer	5.15e-05	0.000436	CcSEcCtD
Methimazole—Pruritus—Doxorubicin—breast cancer	5.04e-05	0.000426	CcSEcCtD
Methimazole—Vomiting—Epirubicin—breast cancer	4.89e-05	0.000414	CcSEcCtD
Methimazole—Nausea—Methotrexate—breast cancer	4.88e-05	0.000413	CcSEcCtD
Methimazole—Rash—Epirubicin—breast cancer	4.85e-05	0.00041	CcSEcCtD
Methimazole—Dermatitis—Epirubicin—breast cancer	4.85e-05	0.00041	CcSEcCtD
Methimazole—Headache—Epirubicin—breast cancer	4.82e-05	0.000408	CcSEcCtD
Methimazole—Nausea—Epirubicin—breast cancer	4.57e-05	0.000386	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—breast cancer	4.53e-05	0.000383	CcSEcCtD
Methimazole—Rash—Doxorubicin—breast cancer	4.49e-05	0.00038	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—breast cancer	4.48e-05	0.000379	CcSEcCtD
Methimazole—Headache—Doxorubicin—breast cancer	4.46e-05	0.000377	CcSEcCtD
Methimazole—Nausea—Doxorubicin—breast cancer	4.23e-05	0.000358	CcSEcCtD
Methimazole—CYP1A2—Metabolism—CPT1A—breast cancer	4.1e-06	4.23e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCG2—breast cancer	4.1e-06	4.23e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.07e-06	4.2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTA2—breast cancer	4.07e-06	4.2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GPX2—breast cancer	4.07e-06	4.2e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP3A4—breast cancer	4.06e-06	4.19e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GPX1—breast cancer	4.04e-06	4.17e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.04e-06	4.17e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—FASN—breast cancer	4.03e-06	4.16e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HPGDS—breast cancer	4.02e-06	4.15e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SULT1A1—breast cancer	4.02e-06	4.15e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GPX4—breast cancer	4.02e-06	4.15e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—BCHE—breast cancer	4.01e-06	4.14e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP1A1—breast cancer	4e-06	4.13e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HBA1—breast cancer	4e-06	4.12e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—FASN—breast cancer	3.99e-06	4.12e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP1B1—breast cancer	3.99e-06	4.12e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—BCHE—breast cancer	3.98e-06	4.1e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ERCC2—breast cancer	3.97e-06	4.09e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC5A5—breast cancer	3.96e-06	4.09e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GPX1—breast cancer	3.96e-06	4.08e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC5A5—breast cancer	3.93e-06	4.05e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTA1—breast cancer	3.93e-06	4.05e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—IDH1—breast cancer	3.93e-06	4.05e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP1A1—breast cancer	3.92e-06	4.04e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.91e-06	4.04e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTT1—breast cancer	3.9e-06	4.03e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ACHE—breast cancer	3.9e-06	4.03e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ERCC2—breast cancer	3.89e-06	4.01e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CG—breast cancer	3.88e-06	4.01e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NAT2—breast cancer	3.88e-06	4.01e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC2A1—breast cancer	3.83e-06	3.95e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NQO1—breast cancer	3.83e-06	3.95e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NCOA1—breast cancer	3.81e-06	3.93e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NQO1—breast cancer	3.79e-06	3.91e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC2A1—breast cancer	3.79e-06	3.91e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—STK11—breast cancer	3.75e-06	3.87e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP19A1—breast cancer	3.75e-06	3.87e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP3A4—breast cancer	3.73e-06	3.85e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—MTHFR—breast cancer	3.73e-06	3.85e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.72e-06	3.83e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP3A4—breast cancer	3.7e-06	3.82e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP17A1—breast cancer	3.69e-06	3.81e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.68e-06	3.8e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP1B1—breast cancer	3.67e-06	3.79e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS1—breast cancer	3.66e-06	3.77e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ENO1—breast cancer	3.66e-06	3.77e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—MTHFR—breast cancer	3.65e-06	3.77e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.64e-06	3.76e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP1B1—breast cancer	3.64e-06	3.75e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.6e-06	3.71e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.6e-06	3.71e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP2D6—breast cancer	3.59e-06	3.7e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.57e-06	3.68e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.52e-06	3.63e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NCOA2—breast cancer	3.52e-06	3.63e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NCOA1—breast cancer	3.5e-06	3.61e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—COMT—breast cancer	3.49e-06	3.6e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTP1—breast cancer	3.47e-06	3.58e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NCOA1—breast cancer	3.47e-06	3.58e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP19A1—breast cancer	3.45e-06	3.56e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—STK11—breast cancer	3.45e-06	3.56e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CAV1—breast cancer	3.44e-06	3.55e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—HMOX1—breast cancer	3.42e-06	3.53e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—STK11—breast cancer	3.42e-06	3.53e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP19A1—breast cancer	3.42e-06	3.53e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ITPR1—breast cancer	3.41e-06	3.52e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CD—breast cancer	3.41e-06	3.52e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—FASN—breast cancer	3.41e-06	3.52e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MED12—breast cancer	3.4e-06	3.51e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—DPYD—breast cancer	3.4e-06	3.51e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—BCHE—breast cancer	3.4e-06	3.51e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ALB—breast cancer	3.37e-06	3.48e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CAV1—breast cancer	3.37e-06	3.48e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC5A5—breast cancer	3.36e-06	3.46e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALDOA—breast cancer	3.35e-06	3.46e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ABCB1—breast cancer	3.29e-06	3.39e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOA3—breast cancer	3.25e-06	3.36e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC2A1—breast cancer	3.24e-06	3.35e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NQO1—breast cancer	3.24e-06	3.35e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC2A2—breast cancer	3.23e-06	3.33e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—TYMS—breast cancer	3.23e-06	3.33e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—NOS3—breast cancer	3.22e-06	3.33e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.21e-06	3.31e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—COMT—breast cancer	3.21e-06	3.31e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTP1—breast cancer	3.19e-06	3.29e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NCOR1—breast cancer	3.19e-06	3.29e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.19e-06	3.29e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTM1—breast cancer	3.19e-06	3.29e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—COMT—breast cancer	3.18e-06	3.28e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.17e-06	3.28e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCG2—breast cancer	3.17e-06	3.27e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MTR—breast cancer	3.17e-06	3.27e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CPT1A—breast cancer	3.17e-06	3.27e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTP1—breast cancer	3.16e-06	3.26e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP3A4—breast cancer	3.16e-06	3.26e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—HMOX1—breast cancer	3.15e-06	3.25e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.15e-06	3.25e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ITPR1—breast cancer	3.14e-06	3.24e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CG—breast cancer	3.13e-06	3.23e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—HMOX1—breast cancer	3.12e-06	3.22e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ITPR1—breast cancer	3.11e-06	3.21e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP1B1—breast cancer	3.11e-06	3.21e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HPGDS—breast cancer	3.1e-06	3.2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HBA1—breast cancer	3.08e-06	3.18e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CG—breast cancer	3.07e-06	3.17e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GPX1—breast cancer	3.05e-06	3.15e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.05e-06	3.15e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP1A1—breast cancer	3.02e-06	3.12e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ABCB1—breast cancer	3.02e-06	3.12e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ACHE—breast cancer	3.01e-06	3.11e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTT1—breast cancer	3.01e-06	3.11e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ERCC2—breast cancer	3e-06	3.09e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ABCB1—breast cancer	3e-06	3.09e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CB—breast cancer	2.98e-06	3.07e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—TYMS—breast cancer	2.97e-06	3.06e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NCOA1—breast cancer	2.97e-06	3.06e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTGS2—breast cancer	2.95e-06	3.04e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—TYMS—breast cancer	2.94e-06	3.04e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NCOR1—breast cancer	2.93e-06	3.03e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.93e-06	3.03e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTM1—breast cancer	2.93e-06	3.03e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—STK11—breast cancer	2.92e-06	3.02e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP19A1—breast cancer	2.92e-06	3.02e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTM1—breast cancer	2.91e-06	3e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.91e-06	3e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NCOR1—breast cancer	2.91e-06	3e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP17A1—breast cancer	2.85e-06	2.94e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS1—breast cancer	2.82e-06	2.91e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ENO1—breast cancer	2.82e-06	2.91e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—MTHFR—breast cancer	2.82e-06	2.91e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GPX1—breast cancer	2.81e-06	2.9e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GPX1—breast cancer	2.78e-06	2.87e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP1A1—breast cancer	2.78e-06	2.87e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2D6—breast cancer	2.77e-06	2.85e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ERCC2—breast cancer	2.76e-06	2.85e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP1A1—breast cancer	2.76e-06	2.84e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CD—breast cancer	2.75e-06	2.84e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.74e-06	2.83e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ERCC2—breast cancer	2.73e-06	2.82e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ALB—breast cancer	2.72e-06	2.81e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—COMT—breast cancer	2.72e-06	2.8e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOA2—breast cancer	2.72e-06	2.8e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTP1—breast cancer	2.7e-06	2.79e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CD—breast cancer	2.7e-06	2.78e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HMOX1—breast cancer	2.67e-06	2.75e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ALB—breast cancer	2.66e-06	2.75e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ITPR1—breast cancer	2.66e-06	2.75e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—FASN—breast cancer	2.63e-06	2.72e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—BCHE—breast cancer	2.62e-06	2.71e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—NOS3—breast cancer	2.6e-06	2.68e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CAV1—breast cancer	2.6e-06	2.68e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—MTHFR—breast cancer	2.59e-06	2.67e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC5A5—breast cancer	2.59e-06	2.67e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTEN—breast cancer	2.57e-06	2.65e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—MTHFR—breast cancer	2.57e-06	2.65e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCB1—breast cancer	2.56e-06	2.64e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NOS3—breast cancer	2.55e-06	2.63e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—TYMS—breast cancer	2.51e-06	2.59e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NQO1—breast cancer	2.5e-06	2.58e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC2A1—breast cancer	2.5e-06	2.58e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTM1—breast cancer	2.48e-06	2.56e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.48e-06	2.56e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NCOR1—breast cancer	2.48e-06	2.56e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.48e-06	2.56e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CB—breast cancer	2.4e-06	2.48e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP1B1—breast cancer	2.4e-06	2.48e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CAV1—breast cancer	2.39e-06	2.47e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GPX1—breast cancer	2.38e-06	2.46e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTGS2—breast cancer	2.38e-06	2.45e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CAV1—breast cancer	2.37e-06	2.45e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CG—breast cancer	2.37e-06	2.44e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP1A1—breast cancer	2.36e-06	2.43e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.35e-06	2.43e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CB—breast cancer	2.35e-06	2.43e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ERCC2—breast cancer	2.34e-06	2.41e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTGS2—breast cancer	2.33e-06	2.4e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOA1—breast cancer	2.29e-06	2.36e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.26e-06	2.34e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—STK11—breast cancer	2.26e-06	2.33e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP19A1—breast cancer	2.26e-06	2.33e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—MTHFR—breast cancer	2.2e-06	2.27e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CG—breast cancer	2.18e-06	2.25e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CG—breast cancer	2.16e-06	2.23e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—COMT—breast cancer	2.1e-06	2.16e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTP1—breast cancer	2.09e-06	2.15e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CD—breast cancer	2.08e-06	2.15e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTEN—breast cancer	2.07e-06	2.14e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HMOX1—breast cancer	2.06e-06	2.12e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ALB—breast cancer	2.06e-06	2.12e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ITPR1—breast cancer	2.05e-06	2.12e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTEN—breast cancer	2.03e-06	2.1e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CAV1—breast cancer	2.03e-06	2.09e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCB1—breast cancer	1.98e-06	2.04e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NOS3—breast cancer	1.97e-06	2.03e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—TYMS—breast cancer	1.94e-06	2e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.94e-06	2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTM1—breast cancer	1.92e-06	1.98e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOR1—breast cancer	1.92e-06	1.98e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.92e-06	1.98e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CD—breast cancer	1.91e-06	1.98e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CD—breast cancer	1.9e-06	1.96e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ALB—breast cancer	1.89e-06	1.95e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ALB—breast cancer	1.87e-06	1.93e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CG—breast cancer	1.85e-06	1.9e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GPX1—breast cancer	1.84e-06	1.89e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP1A1—breast cancer	1.82e-06	1.88e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CB—breast cancer	1.81e-06	1.87e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CA—breast cancer	1.81e-06	1.87e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NOS3—breast cancer	1.81e-06	1.87e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ERCC2—breast cancer	1.8e-06	1.86e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTGS2—breast cancer	1.8e-06	1.86e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NOS3—breast cancer	1.79e-06	1.85e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MTHFR—breast cancer	1.69e-06	1.75e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CB—breast cancer	1.67e-06	1.72e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CB—breast cancer	1.65e-06	1.71e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTGS2—breast cancer	1.65e-06	1.71e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTGS2—breast cancer	1.64e-06	1.69e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CD—breast cancer	1.62e-06	1.67e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALB—breast cancer	1.6e-06	1.65e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTEN—breast cancer	1.57e-06	1.62e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CAV1—breast cancer	1.56e-06	1.61e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NOS3—breast cancer	1.53e-06	1.58e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKT1—breast cancer	1.48e-06	1.53e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CA—breast cancer	1.46e-06	1.51e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTEN—breast cancer	1.44e-06	1.49e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CA—breast cancer	1.43e-06	1.48e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTEN—breast cancer	1.43e-06	1.48e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CG—breast cancer	1.42e-06	1.47e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CB—breast cancer	1.41e-06	1.46e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS2—breast cancer	1.4e-06	1.45e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CD—breast cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALB—breast cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTEN—breast cancer	1.22e-06	1.26e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKT1—breast cancer	1.2e-06	1.23e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NOS3—breast cancer	1.18e-06	1.22e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKT1—breast cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CA—breast cancer	1.11e-06	1.14e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CB—breast cancer	1.09e-06	1.13e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS2—breast cancer	1.08e-06	1.12e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CA—breast cancer	1.02e-06	1.05e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CA—breast cancer	1.01e-06	1.04e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTEN—breast cancer	9.43e-07	9.73e-06	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKT1—breast cancer	9.04e-07	9.32e-06	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CA—breast cancer	8.62e-07	8.89e-06	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKT1—breast cancer	8.31e-07	8.58e-06	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKT1—breast cancer	8.24e-07	8.5e-06	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKT1—breast cancer	7.04e-07	7.26e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CA—breast cancer	6.65e-07	6.86e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKT1—breast cancer	5.43e-07	5.61e-06	CbGpPWpGaD
